World Hepatitis Alliance (the Alliance), European Liver Patient Association (ELPA) and Bristol-Myers Squibb Announce Global Expansion of PATH B Programme on World Hepatitis Day to Address the Unmet Need in Resources for People Living with Chronic Hepatitis B
Patients and Professionals Acting Together for Hepatitis B (PATH B), www.pathb.com, provides the most comprehensive information and tools available for those at risk and diagnosed with chronic hepatitis B
PATH B expands roll-out to six countries and is now available in the UK, Italy, Portugal, Russia, Spain, Taiwan and Turkey
[Paris, 26 July 2012] – The World Hepatitis Alliance (the Alliance), European Liver Patients Association (ELPA) and Bristol-Myers Squibb announced today that the successful PATH B programme has been expanded to support patients living with chronic hepatitis B in a further six countries, with additional countries under consideration.
Since the launch of PATH B in the UK in October 2011, the programme has received a large number of requests for it to be available in other countries. This demonstrates that credible, accurate patient resources are highly sought after by not only patients, but also physicians, in a disease area where little or no resources exist.
PATH B is provided as an educational service by the Alliance and ELPA, and is organised and funded through an unrestricted grant by Bristol-Myers Squibb. The programme is managed by an independent advisory board consisting of patient advocacy group representatives and leading hepatologists from across Europe.
Click here to read full press release
